MPC Therapeutics

Great team meeting at the fantastically located, equipped and decorated PepperHub - Centre d'affaires in Gland! Thanks Jean Philippe KUNZ for the invitation!

After one decade of CD19-CAR T cell therapy, this paper determined for the first time the characteristics of the CAR T cell therapeutic product inducing very long-term (> 8 years) remission. They found that beyond a T helper 2 signature, a memory gene signature significantly correlates with durable remission. S The good news, is that at MPC Therapeutics, we are working to improve precisely these markers in CAR-T preparations. We aim to enrich therapies with stem cell-like and central memory T-cells, which play a key role the persistence and durable efficacy of cell therapies. In the coming months, we will reach out to our partners to propose our latest technology, MitoStemX, for evaluation and licensing…   Stay tuned... More to follow   Congratulations to the authors for their recent publication in Nature. https://lnkd.in/e2CPGGyN

Meet our team in the road this month! - This Thursday and Friday Raphaël Martinou and Augustin de Bettignies will at MATWIN's #MeettoWin congress in Bordeaux. We'll showcase our latest results in the poster session on Thursday evening - Wednesday 22nd, we'll be at the first edition of "Innovation in Cell and Gene Therapy" summit organised by MabDesign Network and SFTCG-French Society for Cell and Gene Therapy in Paris. - Thursday 30th and Friday 31st, our CTO Mathias Wenes will be opening the VIB Recent insights in #ImmunoOnco2024 in Leuven. We look forward to interacting with you there and then!

We will be sharing our latest results at the MATWIN congress in May. It's a great place for oncology startups to connect with industry and investment professionals... We hope to see you there!

Donor-to-donor variability has long been recognized as a challenge in cell therapy. However, it's crucial to recognize that manufacturing systems also play a significant role in shaping cell therapy products. Check this insightful paper from the NIH looking at how leading systems, and cellular oxygenation in particular, influence cell expansion, phenotypes & metabolism. Congrats to all the authors ! cc Hannah W. Song Steven Highfill https://lnkd.in/epjn5GPu

Join us today at 12:40 at the CAR-TCR Summit in London! Our CTO, Mathias Wenes will be taking the stage to present how MITO-66, our novel small molecule targeting metabolism, enhances the fitness and durability of CAR T cells against cancer. Join us for his presentation and feel free to connect with us afterward if you'd like to learn more about our innovative science. See you there ! #cartcelltherapy #cancertreatment #mitochondria

Our CTO Mathias Wenes will be sharing some recent data at the 7th CAR-TCR Summit Europe in London this February 27-29!   We encourage your attendance at this European meeting dedicated to advancing CAR-T and TCR therapies through next generation approaches and innovations. Do reach out to us to schedule a meeting with Mathias on site! #CART #cartcelltherapy #tcr #mitochondria

Greetings from our brand-new lab and office space at La Tulipe in Geneva! As we step into 2024, our growing team is thrilled to wish you a fantastic year ahead! We're embarking on groundbreaking partnering activities and delving into exciting therapeutic research. Join us on this journey for innovative therapies against cancer and ageing! Stay tuned for some major announcements in the coming weeks...

Delighted to share we've been awarded a convertible loan from the Fongit Innovation Fund. This support from our Canton comes at a great time. We are at the eve of an important year : in 2024, we expect to generate our first revenues from our cell therapy adjuvant projects and accelerate our therapeutic project in the neurogenerative space... We would like to thank our coach Marco Rüedi, MD, eMBA, eMMM and evaluators Christine Deuschel & Emmanuel de Watteville for their trust and support. Congrats to the extended team Raphaël Martinou, Augustin de Bettignies, Mathias Wenes, Jean-Claude Martinou, Kaushik Bhattacharya, Cédric Boudou, Jean Philippe KUNZ. Do note we are currently raising funds, so do reach out to us to know more!